All stock lists
Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
Healthcare · Biotechnology
8.41-0.24 (-2.77%)
Insider Score
––Not scored
QTTB Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
QTTB analyst forecast
QTTB analyst consensus
No analyst ratings in the last 3 months.
QTTB 12-month price target
$35.80+325.7% upsideaverage of 5 firms
$66.00High
$14.00Low
Best analysts covering QTTB
No firm covering QTTB has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
QTTB analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Jefferies | — | $29.00 | +230.7% | — | 2026-09-28 | |
| Morgan Stanley | — | $34.00 | +112.9% | — | 2026-08-24 | |
| H.C. Wainwright | — | $36.00 | +136.7% | — | 2026-07-28 | |
| Wells Fargo | — | $66.00 | +225.3% | — | 2026-07-13 | |
| Mizuho Securities | — | $14.00 | +154.5% | — | 2026-05-22 | |
| H.C. Wainwright | — | $13.00 | +117.0% | — | 2026-03-10 | |
| BMO Capital | — | $64.00 | +170.2% | — | 2024-12-05 | |
| Oppenheimer | — | $80.00 | +65.1% | — | 2024-10-16 | |
| Wells Fargo | — | $95.00 | +87.7% | — | 2024-09-11 | |
| Leerink Partners | — | $54.00 | +78.8% | — | 2024-05-21 | |
| Oppenheimer | — | $50.00 | +132.8% | — | 2024-04-10 | |
| Raymond James | — | $45.00 | +150.0% | — | 2024-04-02 | |
| Piper Sandler | — | $45.00 | +150.0% | — | 2024-04-02 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.